Nygard Biotec
Nygard Biotec

The Movie

Peter Nygards 4 Step Strategy:

Step 1: Obtaining the right technology

University of Oregon Scientist, Dr. Shoukhrat Mitalipov explains, “It’s been 15 years since we invented the embryonic stem cell, and no one has been able to figure out how to use it.”   The procedure inserts adult human DNA into an unfertilised human egg, so that the growing stem cells can be used to treat serious disease and ageing.

 

“The way in which these stem cell lines were derived is from embryos that were created in the process of In Vitro Fertlisation (IVF), and, in fact, there are hundreds of thousands of these embryos that are simply being discarded,” said Dr. Francis Collins, Director of the US National Institute of health.

Step 2: Finding the perfect setting

After lengthy international travels, Mr. Nygard settled in the Bahamas for good reason many years ago.  Recognised by its popularity among A-class celebrities and the rich and famous, the Bahamas is a celebrated holiday destination with beautiful weather, a welcoming economy and an ever-friendly culture.  He believes that his new home would be perfect for both his business and the Bahamian people.

Step 3: Educating the law-makers

Mr Nygard needed the Bahamian government to willingly adopt supportive legislation for his stem cell studies.  This was a critical step in the progression of his extensive plans for research. He says that Bahama’s current Prime Minister Perry Christie "showed tremendous courage and political savviness to guide this through the legislature”.

 

PM Christie states in the video above that:“Two years ago Peter Nygård called me to say that if your country is prepared to pass legislation, I will find a way to bring scientists who I have retained. I am prepared to have them come into the Bahamas.”

 

The stem cell bill was passed in January of 2014 and was the first time the Bahamas’ ‘Medical Act’ had been revised in over 12 years. 

Step 4: Planing and construction of the scientific facilities

The construction of a multi-million dollar facility which develops both genomic sequencing and embryonic stem-cell technology would be the first of its kind anywhere in the world. 

 

While importing the most advanced stem cell technologies available, the aim is to also expand research into commercial genome sequencing (GS). This is described as the mapping of an organism’s entire DNA sequence, potentially used to predict one’s risk of developing a range of genetically inherited pathologies. 

Stem Cell News: Science Daily

Unique insight into development of the human brain: Model of the early embryonic brain (Mon, 25 May 2020)
>> Read more

Image analysis technique provides better understanding of heart cell defects (Tue, 19 May 2020)
>> Read more

New research into stem cell mutations could improve regenerative medicine (Thu, 14 May 2020)
>> Read more

Little skates could hold the key to cartilage therapy in humans (Tue, 12 May 2020)
>> Read more

Scientists show MRI predicts the efficacy of a stem cell therapy for brain injury (Tue, 12 May 2020)
>> Read more

Scientists create first roadmap of human skeletal muscle development (Mon, 11 May 2020)
>> Read more

More selective elimination of leukemia stem cells and blood stem cells (Fri, 08 May 2020)
>> Read more

Accumulation of gene mutations in chronic Graft-versus-host disease (Thu, 07 May 2020)
>> Read more

Cellular mechanism involved in Krabbe disease (Tue, 05 May 2020)
>> Read more

Beta cells from stem cells: Potential for cell replacement therapy (Mon, 27 Apr 2020)
>> Read more

Diabetes reversed in mice with genetically edited stem cells derived from patients (Wed, 22 Apr 2020)
>> Read more

Researchers repurpose classic chemotherapy drug to overcome cancer therapy resistance (Mon, 20 Apr 2020)
>> Read more

Stem cells in human embryos commit to specialization surprisingly early (Fri, 17 Apr 2020)
>> Read more

Review assesses stem cell therapy potential for treating preeclampsia (Thu, 16 Apr 2020)
>> Read more

COPD as a lung stem cell disease (Wed, 15 Apr 2020)
>> Read more

Print Print | Sitemap
© Nygard Biotech